<?xml version="1.0" encoding="UTF-8"?>
<p>In our opinion, during the COVID‐19 pandemic, it is still essential to provide first‐trimester screening for placental complications and to prescribe low‐dose aspirin in women who are identified as high risk for pre‐eclampsia and fetal growth restriction. Based on the current knowledge of the epidemiological situation, the benefits of placental complication prevention outweigh the potential risks of adverse outcome related to the usage of low‐dose aspirin in patients with SARS‐CoV‐2 infection.</p>
